- Home
- ESCA vs CRVO Comparison
ESCA vs CRVO Comparison
Compare ESCA & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESCA | CRVO |
|---|---|---|
| Founded | 1922 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.7M | 78.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ESCA | CRVO |
|---|---|---|
| Price | $14.00 | $7.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | 29.3K | ★ 45.5K |
| Earning Date | 02-25-2026 | 11-10-2025 |
| Dividend Yield | ★ 4.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $241,540,000.00 | $6,159,786.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.00 | N/A |
| P/E Ratio | $15.22 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.41 | $1.92 |
| 52 Week High | $16.99 | $16.94 |
Technical Indicators
Market Signals| Indicator | ESCA | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 70.34 | 44.67 |
| Support Level | $12.67 | $7.43 |
| Resistance Level | $14.02 | $7.85 |
| Average True Range (ATR) | 0.34 | 0.51 |
| MACD | 0.09 | -0.06 |
| Stochastic Oscillator | 94.90 | 37.06 |
Price Performance
Historical ComparisonAbout ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.